Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 4Breast 3Lymphoid 2Sarcoma 1Other hematologic neoplasm 1

Conditions

Breast Neoplasms 13110Triple Negative Breast Neoplasms 1145Neoplasms 748Ovarian Neoplasms 676Neoplasm Metastasis 588Lung Neoplasms 581Colorectal Neoplasms 576Prostatic Neoplasms 559Carcinoma, Non-Small-Cell Lung 533Pancreatic Neoplasms 380Melanoma 366Stomach Neoplasms 349Colonic Neoplasms 330Motor Activity 285Breast Neoplasms, Male 285Carcinoma, Intraductal, Noninfiltrating 277Uterine Cervical Neoplasms 265Head and Neck Neoplasms 265Endometrial Neoplasms 254Carcinoma, Renal Cell 215Sarcoma 202Urinary Bladder Neoplasms 192Squamous Cell Carcinoma of Head and Neck 190Lymphedema 190Breast Carcinoma In Situ 189Esophageal Neoplasms 188Brain Neoplasms 183Fatigue 166Carcinoma, Ovarian Epithelial 151Breast Cancer Female 148

Interventions

Sugars 1Donepezil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Memory Disorders × Breast × Clear all
NCT02822573 2023-09-13

Remember

Wake Forest University Health Sciences

Phase 3 Completed
276 enrolled 33 charts
Breast

Breast Neoplasms, Memory Disorders, Cognitive Dysfunction

NCT03420105 2020-03-09

PROSOM-K

Centre Francois Baclesse

Phase NA Completed
75 enrolled
Breast

Breast Neoplasms, Memory Disorders

NCT00387062 2008-06-24

Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment

Posit Science Corporation

Phase 1 Completed
50 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Memory Disorders, Neurobehavioral Manifestations, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡